Sputnik 2.0? Chinese research team first to try CRISPR-Cas9 gene-editing tech on a human
Call it a CRISPR-Cas9 gap.
A little more than two weeks ago Chinese investigators delivered genes edited with CRISPR-Cas9 tech into a lung cancer patient as part of a clinical trial, reports Nature. It was the first use of CRISPR-Cas9 in humans, beating out Carl June at the University of Pennsylvania by several months.
And June — who helped pioneer CAR-T tech in a showdown with rivals like Juno and Kite — sees a duel developing between East and West. And that’s not necessarily a bad thing.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
